<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Nelson Pediatrics â€” Part X: The Fetus and the Neonatal Infant</title>
<link href="https://fonts.googleapis.com/css2?family=Playfair+Display:wght@400;700;900&family=DM+Sans:wght@300;400;500;600&family=DM+Mono:wght@400;500&display=swap" rel="stylesheet">
<style>
  :root {
    --bg: #0d1117;
    --surface: #161b22;
    --surface2: #1c2333;
    --border: #30363d;
    --accent: #e8a44a;
    --accent2: #5caaee;
    --accent3: #63d98a;
    --danger: #f07a7a;
    --text: #e6edf3;
    --text-muted: #8b949e;
    --text-dim: #484f58;
  }

  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: var(--bg);
    color: var(--text);
    font-family: 'DM Sans', sans-serif;
    font-weight: 300;
    line-height: 1.75;
    min-height: 100vh;
  }

  body::before {
    content: '';
    position: fixed;
    inset: 0;
    background-image: url("data:image/svg+xml,%3Csvg viewBox='0 0 256 256' xmlns='http://www.w3.org/2000/svg'%3E%3Cfilter id='noise'%3E%3CfeTurbulence type='fractalNoise' baseFrequency='0.9' numOctaves='4' stitchTiles='stitch'/%3E%3C/filter%3E%3Crect width='100%25' height='100%25' filter='url(%23noise)' opacity='0.04'/%3E%3C/svg%3E");
    pointer-events: none;
    z-index: 0;
    opacity: 0.4;
  }

  .page-wrap {
    position: relative;
    z-index: 1;
    max-width: 920px;
    margin: 0 auto;
    padding: 0 24px 80px;
  }

  .hero {
    padding: 72px 0 48px;
    border-bottom: 1px solid var(--border);
    margin-bottom: 48px;
    position: relative;
    overflow: hidden;
  }

  .hero::after {
    content: 'X';
    position: absolute;
    right: -10px;
    top: 10px;
    font-family: 'Playfair Display', serif;
    font-size: 240px;
    font-weight: 900;
    color: var(--border);
    line-height: 1;
    pointer-events: none;
    user-select: none;
  }

  .hero-tag {
    display: inline-flex;
    align-items: center;
    gap: 8px;
    background: rgba(232,164,74,0.1);
    border: 1px solid rgba(232,164,74,0.3);
    color: var(--accent);
    font-family: 'DM Mono', monospace;
    font-size: 11px;
    letter-spacing: 0.12em;
    text-transform: uppercase;
    padding: 5px 12px;
    border-radius: 4px;
    margin-bottom: 20px;
  }

  .hero-tag::before {
    content: '';
    width: 6px; height: 6px;
    border-radius: 50%;
    background: var(--accent);
    animation: pulse 2s ease-in-out infinite;
  }

  @keyframes pulse {
    0%, 100% { opacity: 1; transform: scale(1); }
    50% { opacity: 0.4; transform: scale(0.8); }
  }

  .hero h1 {
    font-family: 'Playfair Display', serif;
    font-size: clamp(28px, 4.5vw, 48px);
    font-weight: 900;
    line-height: 1.1;
    margin-bottom: 12px;
    color: var(--text);
  }

  .hero h1 span { color: var(--accent); }

  .hero-sub {
    font-size: 15px;
    color: var(--text-muted);
    max-width: 560px;
    margin-bottom: 28px;
  }

  .hero-meta {
    display: flex;
    gap: 24px;
    flex-wrap: wrap;
  }

  .meta-pill {
    display: flex;
    align-items: center;
    gap: 6px;
    font-size: 12px;
    color: var(--text-muted);
    font-family: 'DM Mono', monospace;
  }

  .meta-pill .dot { width: 8px; height: 8px; border-radius: 50%; }

  .search-bar {
    position: sticky;
    top: 0;
    z-index: 100;
    background: rgba(13,17,23,0.92);
    backdrop-filter: blur(12px);
    border-bottom: 1px solid var(--border);
    padding: 12px 0;
    margin-bottom: 36px;
  }

  .search-inner {
    max-width: 920px;
    margin: 0 auto;
    padding: 0 24px;
    display: flex;
    align-items: center;
    gap: 12px;
  }

  .search-input {
    flex: 1;
    background: var(--surface);
    border: 1px solid var(--border);
    border-radius: 8px;
    padding: 8px 14px 8px 36px;
    color: var(--text);
    font-family: 'DM Sans', sans-serif;
    font-size: 14px;
    outline: none;
    transition: border-color 0.2s;
    background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='16' height='16' viewBox='0 0 24 24' fill='none' stroke='%238b949e' stroke-width='2'%3E%3Ccircle cx='11' cy='11' r='8'/%3E%3Cpath d='m21 21-4.35-4.35'/%3E%3C/svg%3E");
    background-repeat: no-repeat;
    background-position: 10px center;
  }

  .search-input:focus { border-color: var(--accent); }
  .search-input::placeholder { color: var(--text-dim); }

  .chapter-count {
    font-family: 'DM Mono', monospace;
    font-size: 11px;
    color: var(--text-muted);
    white-space: nowrap;
  }

  .stats-strip {
    display: grid;
    grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
    gap: 12px;
    margin-bottom: 48px;
  }

  .stat-card {
    background: var(--surface);
    border: 1px solid var(--border);
    border-radius: 10px;
    padding: 16px 18px;
    transition: border-color 0.2s, transform 0.2s;
  }

  .stat-card:hover { border-color: var(--accent); transform: translateY(-2px); }

  .stat-label {
    font-family: 'DM Mono', monospace;
    font-size: 10px;
    text-transform: uppercase;
    letter-spacing: 0.1em;
    color: var(--text-muted);
    margin-bottom: 6px;
  }

  .stat-value {
    font-family: 'Playfair Display', serif;
    font-size: 22px;
    font-weight: 700;
    color: var(--accent);
  }

  .stat-desc { font-size: 12px; color: var(--text-muted); margin-top: 2px; }

  .hiyield {
    background: linear-gradient(135deg, rgba(232,164,74,0.08), rgba(232,164,74,0.03));
    border: 1px solid rgba(232,164,74,0.25);
    border-left: 3px solid var(--accent);
    border-radius: 10px;
    padding: 20px 24px;
    margin-bottom: 48px;
  }

  .hiyield-header {
    display: flex;
    align-items: center;
    gap: 8px;
    font-family: 'DM Mono', monospace;
    font-size: 11px;
    text-transform: uppercase;
    letter-spacing: 0.12em;
    color: var(--accent);
    margin-bottom: 14px;
  }

  .hiyield ul {
    list-style: none;
    display: grid;
    grid-template-columns: repeat(auto-fill, minmax(300px, 1fr));
    gap: 8px;
  }

  .hiyield ul li {
    font-size: 13px;
    color: var(--text);
    padding-left: 16px;
    position: relative;
    line-height: 1.5;
  }

  .hiyield ul li::before {
    content: 'â–¸';
    position: absolute;
    left: 0;
    color: var(--accent);
    font-size: 11px;
  }

  strong.hl  { color: var(--accent);  font-weight: 600; }
  strong.hl2 { color: var(--accent2); font-weight: 600; }
  strong.hl3 { color: var(--accent3); font-weight: 600; }
  strong.hld { color: var(--danger);  font-weight: 600; }

  .section-label {
    font-family: 'DM Mono', monospace;
    font-size: 11px;
    text-transform: uppercase;
    letter-spacing: 0.14em;
    color: var(--text-muted);
    margin-bottom: 16px;
    display: flex;
    align-items: center;
    gap: 10px;
  }

  .section-label::after {
    content: '';
    flex: 1;
    height: 1px;
    background: var(--border);
  }

  .chapters-grid {
    display: flex;
    flex-direction: column;
    gap: 12px;
    margin-bottom: 48px;
  }

  .chapter-card {
    background: var(--surface);
    border: 1px solid var(--border);
    border-radius: 12px;
    overflow: hidden;
    transition: border-color 0.2s, box-shadow 0.2s;
  }

  .chapter-card:hover {
    border-color: rgba(92,170,238,0.4);
    box-shadow: 0 4px 20px rgba(0,0,0,0.3);
  }

  .chapter-header {
    display: flex;
    align-items: center;
    gap: 14px;
    padding: 16px 20px;
    cursor: pointer;
    user-select: none;
  }

  .ch-num {
    font-family: 'DM Mono', monospace;
    font-size: 11px;
    font-weight: 500;
    color: var(--text-muted);
    background: var(--surface2);
    border: 1px solid var(--border);
    border-radius: 6px;
    padding: 3px 8px;
    white-space: nowrap;
    min-width: 42px;
    text-align: center;
  }

  .ch-title {
    flex: 1;
    font-size: 15px;
    font-weight: 500;
    color: var(--text);
  }

  .ch-tags { display: flex; gap: 6px; flex-wrap: wrap; }

  .tag {
    font-family: 'DM Mono', monospace;
    font-size: 9px;
    text-transform: uppercase;
    letter-spacing: 0.08em;
    padding: 2px 7px;
    border-radius: 4px;
    border: 1px solid;
  }

  .tag-hiy  { color: var(--accent);  border-color: rgba(232,164,74,0.3);  background: rgba(232,164,74,0.08); }
  .tag-eth  { color: var(--accent2); border-color: rgba(92,170,238,0.3);  background: rgba(92,170,238,0.08); }
  .tag-soc  { color: var(--accent3); border-color: rgba(99,217,138,0.3);  background: rgba(99,217,138,0.08); }
  .tag-crit { color: var(--danger);  border-color: rgba(240,122,122,0.3); background: rgba(240,122,122,0.08); }

  .ch-toggle {
    color: var(--text-muted);
    font-size: 18px;
    transition: transform 0.3s;
    line-height: 1;
  }

  .chapter-card.open .ch-toggle { transform: rotate(180deg); }

  .chapter-body {
    display: none;
    padding: 0 20px 20px 20px;
    border-top: 1px solid var(--border);
    animation: slideIn 0.2s ease;
  }

  @keyframes slideIn {
    from { opacity: 0; transform: translateY(-6px); }
    to   { opacity: 1; transform: translateY(0); }
  }

  .chapter-card.open .chapter-body { display: block; }

  .chapter-body p {
    font-size: 14px;
    color: var(--text-muted);
    line-height: 1.8;
    margin-top: 14px;
    margin-bottom: 10px;
  }

  .key-points {
    list-style: none;
    display: flex;
    flex-direction: column;
    gap: 6px;
    margin-top: 10px;
  }

  .key-points li {
    font-size: 13.5px;
    color: var(--text);
    padding: 8px 12px;
    background: var(--surface2);
    border-radius: 6px;
    border-left: 2px solid var(--border);
    line-height: 1.6;
  }

  .key-points li.imp  { border-left-color: var(--accent); }
  .key-points li.crit { border-left-color: var(--danger); }
  .key-points li.note { border-left-color: var(--accent2); }

  .mnemonic {
    margin-top: 12px;
    background: rgba(99,217,138,0.07);
    border: 1px dashed rgba(99,217,138,0.25);
    border-radius: 8px;
    padding: 10px 14px;
    font-size: 13px;
    color: var(--accent3);
  }

  .mnemonic::before { content: 'ðŸ’¡ '; }

  .progress-wrap { margin-bottom: 32px; }

  .progress-label {
    font-family: 'DM Mono', monospace;
    font-size: 11px;
    color: var(--text-muted);
    margin-bottom: 6px;
    display: flex;
    justify-content: space-between;
  }

  .progress-bar {
    height: 4px;
    background: var(--border);
    border-radius: 2px;
    overflow: hidden;
  }

  .progress-fill {
    height: 100%;
    background: linear-gradient(90deg, var(--accent), var(--accent2));
    border-radius: 2px;
    width: 0%;
    transition: width 0.4s ease;
  }

  .footer {
    margin-top: 60px;
    padding-top: 24px;
    border-top: 1px solid var(--border);
    display: flex;
    justify-content: space-between;
    align-items: center;
    font-family: 'DM Mono', monospace;
    font-size: 11px;
    color: var(--text-dim);
  }

  .chapter-card.hidden { display: none; }

  @media (max-width: 600px) {
    .hero::after { font-size: 130px; }
    .stats-strip { grid-template-columns: repeat(2, 1fr); }
    .hiyield ul { grid-template-columns: 1fr; }
    .ch-tags { display: none; }
  }
</style>
</head>
<body>

<div class="search-bar">
  <div class="search-inner">
    <input class="search-input" type="text" id="searchInput" placeholder="Search chapters, topics, keywordsâ€¦" oninput="filterChapters()">
    <span class="chapter-count" id="chapterCount">36 chapters</span>
  </div>
</div>

<div class="page-wrap">

  <!-- HERO -->
  <div class="hero">
    <div class="hero-tag">Nelson Textbook of Pediatrics Â· 22nd Edition Â· 2024</div>
    <h1>Part <span>X</span><br>The Fetus &amp; the Neonatal Infant</h1>
    <p class="hero-sub">Fetal development, perinatal medicine, neonatal resuscitation, prematurity, respiratory distress, hyperbilirubinemia, neonatal infections, and disorders of every organ system in the newborn.</p>
    <div class="hero-meta">
      <span class="meta-pill"><span class="dot" style="background:var(--accent)"></span>Chapters 114â€“149</span>
      <span class="meta-pill"><span class="dot" style="background:var(--accent2)"></span>36 Chapters</span>
      <span class="meta-pill"><span class="dot" style="background:var(--danger)"></span>Most Tested Neonatal Content</span>
    </div>
  </div>

  <!-- STATS -->
  <div class="stats-strip">
    <div class="stat-card">
      <div class="stat-label">Chapters</div>
      <div class="stat-value">36</div>
      <div class="stat-desc">Ch. 114â€“149</div>
    </div>
    <div class="stat-card">
      <div class="stat-label">Key Sections</div>
      <div class="stat-value">7</div>
      <div class="stat-desc">Fetus Â· Delivery Â· Prematurity Â· Resp Â· Jaundice Â· Infection Â· Systems</div>
    </div>
    <div class="stat-card">
      <div class="stat-label">Board Relevance</div>
      <div class="stat-value">â˜…â˜…â˜…â˜…â˜…</div>
      <div class="stat-desc">Neonatal topics = highest-yield on boards</div>
    </div>
    <div class="stat-card">
      <div class="stat-label">Critical Topics</div>
      <div class="stat-value">15+</div>
      <div class="stat-desc">RDS, NEC, Jaundice, Sepsis, HIE, PPHNâ€¦</div>
    </div>
  </div>

  <!-- HIGH YIELD BOX -->
  <div class="hiyield">
    <div class="hiyield-header">âš¡ High-Yield Quick Reference â€” Part X</div>
    <ul>
      <li>Apgar score: 0â€“3 = severe depression; 4â€“6 = moderate; 7â€“10 = normal; assess at 1 &amp; 5 min</li>
      <li>NRP: initial steps â†’ PPV if HR &lt;100 or gasping/apnea â†’ chest compressions if HR &lt;60 â†’ epinephrine</li>
      <li>Preterm: &lt;37 wks; VLBW &lt;1500g; ELBW &lt;1000g; surfactant (poractant/beractant) for RDS</li>
      <li>RDS: preterm, â†“surfactant, ground-glass opacity + air bronchograms; treat with CPAP/surfactant</li>
      <li>TTN: term/late preterm, wet lung (delayed fluid resorption); resolves 24â€“72h; supportive only</li>
      <li>Meconium aspiration: post-term, chemical pneumonitis + air trapping; risk of PPHN</li>
      <li>PPHN: â†‘PVR, Râ†’L shunt, cyanosis; treat with Oâ‚‚, iNO, sildenafil, ECMO</li>
      <li>Neonatal jaundice: physiologic peaks day 2â€“4; <strong class="hld">direct bilirubin â‰¥1 mg/dL = ALWAYS pathologic</strong></li>
      <li>Hemolytic jaundice (ABO/Rh): presents &lt;24h; treat with phototherapy â†’ exchange transfusion</li>
      <li>Kernicterus: unconjugated bilirubin deposits in basal ganglia â†’ choreoathetosis, deafness, upward gaze palsy</li>
      <li>NEC: preterm, bloody stools, abdominal distension, pneumatosis intestinalis on X-ray; NPO + antibiotics</li>
      <li>HIE: perinatal asphyxia â†’ encephalopathy; treat with <strong class="hl">therapeutic hypothermia (33â€“34Â°C Ã— 72h)</strong> if â‰¥36 wks</li>
      <li>GBS sepsis: early (&lt;7 days) vs late (7â€“90 days); penicillin G first-line; maternal IAP prevents early-onset</li>
      <li>Congenital syphilis: snuffles, copper-colored rash on palms/soles, Hutchinson teeth, saber shin; treat with penicillin G</li>
      <li>Neonatal hypoglycemia: glucose &lt;47 mg/dL in symptomatic neonate; treat with IV dextrose (D10W 2 mL/kg bolus)</li>
    </ul>
  </div>

  <!-- PROGRESS BAR -->
  <div class="progress-wrap">
    <div class="progress-label">
      <span>Study Progress</span>
      <span id="progressText">0 / 36 opened</span>
    </div>
    <div class="progress-bar">
      <div class="progress-fill" id="progressFill"></div>
    </div>
  </div>

  <!-- â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• -->
  <!-- SECTION A: FETUS & PERINATAL -->
  <!-- â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• -->
  <div class="section-label">Section A â€” The Fetus &amp; Perinatal Medicine</div>
  <div class="chapters-grid">

    <!-- CH 114 -->
    <div class="chapter-card" data-keywords="fetal development placenta amniotic fluid fetal circulation ductus arteriosus foramen ovale ductus venosus umbilical cord fetal lung maturity L/S ratio surfactant">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 114</span>
        <span class="ch-title">Fetal Growth, Development &amp; Placental Function</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">Fetal circulation: oxygenated blood from placenta â†’ umbilical vein â†’ <strong class="hl">ductus venosus</strong> â†’ IVC â†’ RA â†’ <strong class="hl">foramen ovale</strong> â†’ LA â†’ LV â†’ aorta (bypasses liver and lungs)</li>
          <li class="imp">Pulmonary blood bypasses lungs via <strong class="hl">ductus arteriosus</strong> (PA â†’ aorta); high PVR in fetus</li>
          <li class="imp">At birth: lungs expand â†’ â†“PVR; cord clamping â†’ â†‘SVR; foramen ovale closes (functional); DA closes within 10â€“15h (functional) â†’ 2â€“3 weeks (anatomical)</li>
          <li class="imp">Fetal lung maturity: L/S ratio â‰¥2.0 = mature; <strong class="hl">phosphatidylglycerol (PG)</strong> presence = most reliable marker of maturity</li>
          <li class="note">Amniotic fluid: produced by fetal urine (after 20 wks); regulated by fetal swallowing; oligohydramnios â†’ Potter sequence; polyhydramnios â†’ GI obstruction (duodenal atresia), NMD, anencephaly</li>
          <li class="note">Placenta: produces hCG (maintains corpus luteum), progesterone, estrogen, HPL; site of gas/nutrient exchange; barrier to some (not all) pathogens</li>
        </ul>
        <div class="mnemonic">Fetal shunts: "3 Bypasses" â†’ Ductus Venosus (liver bypass), Foramen Ovale (lung bypass 1), Ductus Arteriosus (lung bypass 2)</div>
      </div>
    </div>

    <!-- CH 115 -->
    <div class="chapter-card" data-keywords="high risk pregnancy prenatal care maternal diabetes hypertension preeclampsia IUGR SGA LGA teratogen drug alcohol tobacco screening antenatal corticosteroids">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 115</span>
        <span class="ch-title">The High-Risk Pregnancy &amp; Maternal Conditions Affecting the Newborn</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp"><strong class="hl">Infant of Diabetic Mother (IDM)</strong>: macrosomia (LGA), neonatal hypoglycemia (â†‘fetal insulin from maternal hyperglycemia â†’ â†“glucose after delivery), polycythemia, hypocalcemia, hyperbilirubinemia, RDS (â†“surfactant from insulin), <strong class="hl">cardiac septal hypertrophy</strong>, congenital anomalies (caudal regression, VSD, TGA)</li>
          <li class="imp">IDM hypoglycemia: onset within 1â€“3h of birth; feed early; IV glucose if symptomatic</li>
          <li class="crit"><strong class="hl">Antenatal corticosteroids</strong> (betamethasone/dexamethasone): given 24â€“34 wks threatened preterm delivery; <strong class="hl">â†“RDS, IVH, NEC, mortality</strong> â€” single most effective intervention for preterm outcomes</li>
          <li class="imp">Preeclampsia effects on fetus: IUGR, oligohydramnios, prematurity, placental abruption; magnesium sulfate (maternal) â†’ neonatal hypermagnesemia (hypotonia, apnea)</li>
          <li class="note">IUGR/SGA (&lt;10th percentile): symmetric (early insult â€” chromosomal, infection) vs asymmetric (late â€” placental insufficiency; brain spared, â†“abdominal circumference first)</li>
          <li class="note">Antenatal steroids do NOT prevent RDS at &gt;34 weeks; rescue surfactant still used postnatally</li>
        </ul>
        <div class="mnemonic">IDM complications: "CHAMP" â†’ Cardiac septal hypertrophy, Hypoglycemia, Anomalies, Macrosomia, Polycythemia</div>
      </div>
    </div>

    <!-- CH 116 -->
    <div class="chapter-card" data-keywords="perinatal asphyxia birth asphyxia fetal distress meconium cord prolapse shoulder dystocia resuscitation Apgar score NRP ventilation">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 116</span>
        <span class="ch-title">Perinatal Asphyxia &amp; Birth Injuries</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">Perinatal asphyxia = impaired gas exchange â†’ hypoxia + hypercapnia + metabolic acidosis; can cause multi-organ dysfunction</li>
          <li class="imp"><strong class="hl">Birth injuries</strong>: cephalohematoma (subperiosteal, does NOT cross suture lines, no treatment needed), caput succedaneum (crosses sutures, resolves quickly), subgaleal hematoma (dangerous â€” can cause hemorrhagic shock)</li>
          <li class="crit"><strong class="hld">Subgaleal hematoma</strong>: blood in subgaleal space; can expand massively â†’ hypovolemic shock, DIC; monitor head circumference closely; vacuum delivery risk factor</li>
          <li class="imp">Erb palsy (C5-C6): upper brachial plexus; "waiter's tip" â€” arm adducted, internally rotated, elbow extended, wrist flexed; shoulder dystocia or traction</li>
          <li class="imp">Klumpke palsy (C8-T1): lower brachial plexus; intrinsic hand muscles affected; Horner syndrome (ptosis, miosis, anhidrosis) if T1 involved</li>
          <li class="note">Facial nerve palsy: forceps delivery; unilateral; usually resolves spontaneously; eye care if incomplete closure</li>
          <li class="note">Clavicle fracture: most common birth fracture; reassurance; heals in 2â€“3 weeks</li>
        </ul>
        <div class="mnemonic">Cephalohematoma vs Caput: "Cephalo = Contained (sutures); Caput = Crosses sutures" â€” caput resolves faster</div>
      </div>
    </div>

    <!-- CH 117 -->
    <div class="chapter-card" data-keywords="neonatal resuscitation NRP Apgar score initial steps PPV chest compressions epinephrine intubation LMA meconium temperature">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 117</span>
        <span class="ch-title">Neonatal Resuscitation (NRP)</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp"><strong class="hl">Apgar Score</strong>: assessed at 1 &amp; 5 min; 5 components (each 0â€“2): <strong class="hl">A</strong>ppearance (color), <strong class="hl">P</strong>ulse (HR), <strong class="hl">G</strong>rimace (reflex), <strong class="hl">A</strong>ctivity (tone), <strong class="hl">R</strong>espiration; 7â€“10 normal; NOT used to decide resuscitation</li>
          <li class="imp">NRP initial steps (first 30 sec): <strong class="hl">Warm, Dry, Stimulate</strong>, clear airway if needed, position</li>
          <li class="crit">Assess: <strong class="hl">HR is the most important indicator</strong> of response to resuscitation</li>
          <li class="crit">PPV if: gasping/apnea OR HR &lt;100 bpm despite initial steps; <strong class="hl">21% Oâ‚‚ for term</strong>; 21â€“30% for preterm</li>
          <li class="crit">Chest compressions if HR &lt;60 despite 30 sec adequate PPV; ratio <strong class="hl">3:1 (compressions:ventilations)</strong></li>
          <li class="crit">Epinephrine: IV/IO preferred (0.01â€“0.03 mg/kg of 1:10,000); ETT route less reliable (0.05â€“0.1 mg/kg)</li>
          <li class="imp">Meconium-stained amniotic fluid: if baby vigorous (good tone, cry, HR) â†’ routine care; if NOT vigorous â†’ intubate and suction trachea before PPV</li>
          <li class="note">Volume: 10 mL/kg NS or O-negative blood for hypovolemia/hemorrhage unresponsive to epi</li>
          <li class="note">Stop resuscitation consideration: if no cardiac activity after 10+ min of complete resuscitation</li>
        </ul>
        <div class="mnemonic">Apgar: "APGAR" â†’ Appearance, Pulse, Grimace, Activity, Respiration â€” scored 0-2 each, max 10</div>
      </div>
    </div>

  </div>

  <!-- â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• -->
  <!-- SECTION B: THE PRETERM INFANT -->
  <!-- â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• -->
  <div class="section-label">Section B â€” The Preterm &amp; Low Birth Weight Infant</div>
  <div class="chapters-grid">

    <!-- CH 118 -->
    <div class="chapter-card" data-keywords="premature preterm VLBW ELBW complications temperature thermoregulation fluid electrolyte nutrition TPN kangaroo care retinopathy ROP BPD IVH NEC apnea bradycardia caffeine">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 118</span>
        <span class="ch-title">The Preterm Infant: Overview &amp; General Management</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">Preterm: &lt;37 wks; VLBW &lt;1500g; ELBW &lt;1000g; LBW &lt;2500g</li>
          <li class="imp">Viability: generally ~22â€“23 wks; survival improves significantly after 25 wks; outcomes vary by center</li>
          <li class="crit">Major complications of prematurity: <strong class="hl">RDS, IVH, NEC, BPD, ROP, apnea of prematurity, sepsis, PDA, hypothermia, hypoglycemia</strong></li>
          <li class="imp">Thermoregulation: preterm at high risk of hypothermia (large SA:mass, thin skin, no brown fat); maintain neutral thermal environment; plastic wrap/warm room for ELBW at delivery</li>
          <li class="imp"><strong class="hl">Apnea of prematurity</strong>: central (â†“respiratory drive), obstructive, or mixed; treat with <strong class="hl">caffeine citrate</strong> (methylxanthine â€” most effective); also CPAP, stimulation</li>
          <li class="imp"><strong class="hl">PDA</strong>: failure of DA to close (â†‘in prematurity due to â†“Oâ‚‚ sensitivity and â†‘PGEâ‚‚); presents with bounding pulses, continuous "machinery" murmur, wide pulse pressure; treat with <strong class="hl">indomethacin or ibuprofen</strong> (COX inhibitors â†’ â†“PGEâ‚‚) or surgical ligation</li>
          <li class="note">Nutrition: early parenteral nutrition (within hours of birth) for VLBW; trophic feeds; human milk preferred (â†“NEC, â†“sepsis, â†‘neurodevelopment)</li>
          <li class="note">Kangaroo mother care: skin-to-skin; improves temperature stability, breastfeeding, neurodevelopment, bonding; â†“mortality in LMICs</li>
        </ul>
        <div class="mnemonic">Preterm complications: "BRING NEC" â†’ BPD, RDS, IVH, NEC, G (glucose issues), NEC, Eyes (ROP), Caffeine (apnea)</div>
      </div>
    </div>

    <!-- CH 119 -->
    <div class="chapter-card" data-keywords="intraventricular hemorrhage IVH germinal matrix grading ultrasound periventricular leukomalacia PVL hydrocephalus neurodevelopmental outcome">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 119</span>
        <span class="ch-title">Intraventricular Hemorrhage (IVH) &amp; Periventricular Leukomalacia (PVL)</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">IVH: most common in ELBW/VLBW infants; originates from fragile <strong class="hl">germinal matrix</strong> (subependymal) vessels; peaks 24â€“72h of life</li>
          <li class="imp"><strong class="hl">Papile grading</strong>: Grade I = germinal matrix only; Grade II = intraventricular, no dilation; Grade III = IVH + ventricular dilation; Grade IV = parenchymal involvement (periventricular hemorrhagic infarction)</li>
          <li class="crit">Grade IIIâ€“IV: high risk of posthemorrhagic hydrocephalus, cerebral palsy, neurodevelopmental impairment</li>
          <li class="imp">Diagnosis: <strong class="hl">cranial ultrasound</strong> â€” screen all &lt;32 wks at 7â€“14 days of life; repeat at 36 wks corrected age</li>
          <li class="imp">Prevention: <strong class="hl">antenatal corticosteroids</strong>, indomethacin (prophylactic), gentle ventilation, avoid rapid fluid shifts, maintain stable BP</li>
          <li class="crit"><strong class="hl">PVL</strong> (periventricular leukomalacia): ischemic injury to periventricular white matter; hallmark of prematurity brain injury; â†‘risk of <strong class="hl">spastic diplegia</strong> (legs &gt; arms â€” periventricular fibers for legs closest to ventricles)</li>
        </ul>
        <div class="mnemonic">PVL â†’ Spastic Diplegia: periventricular fibers for LEGS sit closest to ventricles â€” legs affected most</div>
      </div>
    </div>

    <!-- CH 120 -->
    <div class="chapter-card" data-keywords="retinopathy of prematurity ROP zone stage plus disease VEGF oxygen threshold bevacizumab laser photocoagulation screening">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 120</span>
        <span class="ch-title">Retinopathy of Prematurity (ROP)</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">ROP: disorder of retinal vascular development in preterm infants; hyperoxia â†’ vasoconstriction â†’ hypoxia â†’ â†‘VEGF â†’ abnormal neovascularization</li>
          <li class="imp">Risk factors: gestational age &lt;30 wks, birth weight &lt;1500g, supplemental Oâ‚‚ exposure, sepsis</li>
          <li class="imp">Screening: ophthalmologic exam starting at 31 wks corrected gestational age (or 4 wks postnatal, whichever is later) for all &lt;30 wks or &lt;1500g</li>
          <li class="imp">Classification: <strong class="hl">Zone</strong> (I = most posterior; III = peripheral); <strong class="hl">Stage</strong> (1â€“5); <strong class="hl">Plus disease</strong>: dilation/tortuosity of posterior vessels = active neovascularization</li>
          <li class="crit">Treatment: <strong class="hl">laser photocoagulation</strong> (standard); <strong class="hl">intravitreal bevacizumab (anti-VEGF)</strong> for zone I disease; surgery (vitrectomy) for stage 4â€“5</li>
          <li class="note">Prevention: target SpOâ‚‚ 91â€“95% in preterm (avoid hyperoxia); judicious Oâ‚‚ use</li>
        </ul>
        <div class="mnemonic">ROP screening: "&lt;30 wks or &lt;1500g â†’ eye exam at 4 weeks postnatal or 31 wks corrected (whichever later)"</div>
      </div>
    </div>

    <!-- CH 121 -->
    <div class="chapter-card" data-keywords="bronchopulmonary dysplasia BPD chronic lung disease CLD oxygen dependency supplemental oxygen CPAP ventilator diuretic inhaled steroid pulmonary hypertension">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 121</span>
        <span class="ch-title">Bronchopulmonary Dysplasia (BPD)</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">BPD = chronic lung disease of prematurity; defined as Oâ‚‚ requirement at <strong class="hl">36 weeks PMA</strong> (postmenstrual age)</li>
          <li class="imp">Pathogenesis: arrested alveolar/vascular development (new BPD) + lung injury from Oâ‚‚ toxicity, barotrauma, inflammation (old BPD)</li>
          <li class="imp">Risk factors: extreme prematurity, RDS, mechanical ventilation, Oâ‚‚ toxicity, sepsis, PDA, fluid overload</li>
          <li class="imp">Features: Oâ‚‚ dependency, hyperinflation, atelectasis, pulmonary hypertension, growth failure, recurrent respiratory infections</li>
          <li class="imp">Management: <strong class="hl">minimize ventilator time</strong> (early extubation to CPAP/HFNC), targeted Oâ‚‚ (SpOâ‚‚ 90â€“95%), diuretics (furosemide/thiazides for fluid overload), inhaled bronchodilators, postnatal steroids (dexamethasone â€” facilitates extubation but neurotoxic risk), caffeine</li>
          <li class="note">Pulmonary hypertension complicates severe BPD â†’ sildenafil, iNO; echocardiogram at 36 wks PMA for all severe BPD</li>
          <li class="note">Prevention: antenatal steroids, surfactant, gentle ventilation, caffeine, vitamin A supplementation (â†“BPD in ELBW)</li>
        </ul>
        <div class="mnemonic">BPD = "Oâ‚‚ need at 36 wks PMA" â€” defined by oxygen dependency, not X-ray</div>
      </div>
    </div>

  </div>

  <!-- â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• -->
  <!-- SECTION C: RESPIRATORY DISORDERS OF NEWBORN -->
  <!-- â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• -->
  <div class="section-label">Section C â€” Respiratory Disorders of the Newborn</div>
  <div class="chapters-grid">

    <!-- CH 122 -->
    <div class="chapter-card" data-keywords="respiratory distress syndrome RDS hyaline membrane disease surfactant deficiency ground glass air bronchogram CPAP surfactant replacement lecithin sphingomyelin L/S ratio type II pneumocyte">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 122</span>
        <span class="ch-title">Respiratory Distress Syndrome (RDS) / Hyaline Membrane Disease</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">RDS: most common respiratory disorder of premature infants; â†“surfactant from immature type II pneumocytes â†’ â†‘surface tension â†’ alveolar collapse</li>
          <li class="imp">Risk factors: prematurity (most important), IDM (insulin inhibits surfactant synthesis), male sex, C-section (â†“stress hormones), perinatal asphyxia; â†‘risk: white race</li>
          <li class="imp">Protective: antenatal steroids, female sex, IUGR, heroin exposure (accelerates maturity), prolonged ROM</li>
          <li class="crit">Clinical: onset at birth or shortly after; tachypnea, grunting, flaring, retractions, cyanosis; worsens over 48â€“72h then improves (surfactant production kicks in)</li>
          <li class="imp">CXR: <strong class="hl">ground-glass (reticulogranular) opacification + air bronchograms</strong>, low lung volumes</li>
          <li class="crit">Treatment: <strong class="hl">CPAP (nasal)</strong> â€” first-line for mild-moderate; <strong class="hl">surfactant replacement (intratracheal)</strong> â€” poractant alfa (Curosurf), beractant (Survanta) for moderate-severe; mechanical ventilation for severe; FiOâ‚‚ to keep SpOâ‚‚ 91â€“95%</li>
          <li class="note">INSURE technique: INtubate-SURfactant-Extubate to CPAP â€” minimizes MV exposure</li>
        </ul>
        <div class="mnemonic">RDS CXR: "Ground Glass + Air Bronchograms + Low Volumes" â€” classic preterm pattern</div>
      </div>
    </div>

    <!-- CH 123 -->
    <div class="chapter-card" data-keywords="transient tachypnea newborn TTN wet lung retained fetal fluid C-section term late preterm tachypnea self-limiting oxygen supportive">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 123</span>
        <span class="ch-title">Transient Tachypnea of the Newborn (TTN)</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">TTN = delayed resorption of fetal lung liquid â†’ "wet lung"; most common respiratory disorder of term/near-term neonates</li>
          <li class="imp">Risk factors: <strong class="hl">C-section without labor</strong> (no labor-mediated catecholamine surge to resorb lung fluid), male sex, IDM, macrosomia, late preterm</li>
          <li class="imp">Clinical: tachypnea (RR &gt;60) within hours of birth; usually mild; grunting; resolves within <strong class="hl">24â€“72 hours</strong></li>
          <li class="imp">CXR: fluid in fissures ("wet" appearance), hyperinflation, perihilar streaking, pleural fluid</li>
          <li class="imp">Treatment: <strong class="hl">supportive only</strong> â€” supplemental Oâ‚‚, may need CPAP; resolves spontaneously; no surfactant needed</li>
          <li class="note">Distinguish from RDS: TTN is term/near-term, self-limiting; RDS is preterm, worsens over 48h</li>
        </ul>
        <div class="mnemonic">TTN = "Too Tachypneic Newborn from C-section" â€” wet lung, resolves in 24â€“72h, supportive only</div>
      </div>
    </div>

    <!-- CH 124 -->
    <div class="chapter-card" data-keywords="meconium aspiration syndrome MAS post-term chemical pneumonitis air trapping PPHN surfactant inactivation ball valve hyperinflation CXR">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 124</span>
        <span class="ch-title">Meconium Aspiration Syndrome (MAS)</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">MAS: aspiration of meconium-stained amniotic fluid â†’ airway obstruction (ball-valve â†’ air trapping â†’ pneumothorax) + chemical pneumonitis + surfactant inactivation + PPHN</li>
          <li class="imp">Risk factors: post-term (&gt;42 wks), fetal distress, IUGR, placental insufficiency</li>
          <li class="crit">CXR: <strong class="hl">coarse irregular infiltrates + hyperinflation</strong>; asymmetric patchy opacities; air leak complications</li>
          <li class="crit">Complications: <strong class="hld">PPHN</strong> (most serious â€” hypoxemia refractory to Oâ‚‚), pneumothorax, pneumomediastinum</li>
          <li class="imp">Management: supportive â€” Oâ‚‚, CPAP/ventilation; <strong class="hl">surfactant</strong> (helps inactivation); <strong class="hl">iNO</strong> if PPHN; HFOV; ECMO for refractory cases</li>
          <li class="note">Prevention: earlier delivery in post-term; amnioinfusion does NOT prevent MAS; intubation and suctioning only if baby non-vigorous</li>
        </ul>
        <div class="mnemonic">MAS = "Meconium â†’ Ball-valve â†’ Air trap + Chemical pneumonitis + PPHN" â€” post-term baby in distress</div>
      </div>
    </div>

    <!-- CH 125 -->
    <div class="chapter-card" data-keywords="PPHN persistent pulmonary hypertension newborn right to left shunt iNO inhaled nitric oxide sildenafil ECMO milrinone hyperoxia test preductal postductal SpO2 echo">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 125</span>
        <span class="ch-title">Persistent Pulmonary Hypertension of the Newborn (PPHN)</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">PPHN = failure of PVR to fall at birth â†’ persistent fetal circulation â†’ Râ†’L shunt at foramen ovale and/or DA â†’ severe hypoxemia</li>
          <li class="imp">Causes: MAS, sepsis/pneumonia, RDS, CDH (congenital diaphragmatic hernia), idiopathic, perinatal asphyxia</li>
          <li class="crit">Diagnosis: <strong class="hl">pre-ductal (right hand) SpOâ‚‚ &gt;10% higher than post-ductal (foot)</strong> = Râ†’L ductal shunt; <strong class="hl">hyperoxia test</strong>: PaOâ‚‚ &lt;100 on 100% Oâ‚‚ = fixed Râ†’L shunt; Echo confirms</li>
          <li class="crit">Treatment: <strong class="hld">iNO (inhaled nitric oxide) 20 ppm</strong> â€” selective pulmonary vasodilator, gold standard; also optimize ventilation, treat underlying cause, alkalosis (pH 7.45â€“7.55), <strong class="hl">sildenafil</strong> (PDE-5 inhibitor), milrinone, HFOV</li>
          <li class="crit"><strong class="hld">ECMO</strong>: last resort for refractory PPHN (OI &gt;40); criteria: â‰¥34 wks, &gt;2 kg, reversible condition, no major IVH</li>
          <li class="note">CDH (Congenital Diaphragmatic Hernia): left-sided (80%), bowel in chest â†’ lung hypoplasia + PPHN; stomach bubble in chest on CXR; surgical repair after stabilization</li>
        </ul>
        <div class="mnemonic">PPHN diagnosis: "Pre minus Post SpOâ‚‚ &gt;10% = PPHN (ductal shunt)" â€” right hand vs foot</div>
      </div>
    </div>

    <!-- CH 126 -->
    <div class="chapter-card" data-keywords="air leak pneumothorax pneumomediastinum pulmonary interstitial emphysema PIE tension pneumothorax transillumination needle decompression chest tube">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 126</span>
        <span class="ch-title">Air Leak Syndromes (Pneumothorax, PIE, Pneumomediastinum)</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">Air leak syndromes: air escapes alveoli into adjacent spaces; risk with MAS, RDS, mechanical ventilation, CDH</li>
          <li class="crit"><strong class="hld">Tension pneumothorax</strong>: acute deterioration, â†“breath sounds, mediastinal shift, â†“BP; emergency â€” <strong class="hl">transillumination</strong> (bright light through chest) or CXR; immediate needle decompression (2nd ICS, MCL) â†’ chest tube</li>
          <li class="imp"><strong class="hl">PIE</strong> (Pulmonary Interstitial Emphysema): air dissects into interstitium; cystic appearance on CXR; common in VLBW on ventilator; treat with selective intubation of unaffected lung or HFOV</li>
          <li class="note">Pneumomediastinum: usually benign; thymic sail sign, "spinnaker sail" on CXR; rarely needs treatment</li>
          <li class="note">Spontaneous pneumothorax: occurs in 1â€“2% of normal newborns; small â†’ observation; large/symptomatic â†’ drainage</li>
        </ul>
        <div class="mnemonic">Tension PTX in neonate: "Acute deterioration + unilateral â†“breath sounds â†’ Transilluminate â†’ Needle decompress NOW"</div>
      </div>
    </div>

  </div>

  <!-- â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• -->
  <!-- SECTION D: JAUNDICE & HEMOLYTIC DISEASE -->
  <!-- â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• -->
  <div class="section-label">Section D â€” Neonatal Jaundice &amp; Hemolytic Disease</div>
  <div class="chapters-grid">

    <!-- CH 127 -->
    <div class="chapter-card" data-keywords="neonatal jaundice hyperbilirubinemia physiologic pathologic phototherapy exchange transfusion direct indirect bilirubin Bhutani nomogram kernicterus">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 127</span>
        <span class="ch-title">Neonatal Jaundice &amp; Hyperbilirubinemia</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">Physiologic jaundice: appears day 2â€“3, peaks day 4â€“5, resolves by day 10 (term) or day 14 (preterm); unconjugated bilirubin</li>
          <li class="crit"><strong class="hld">Pathologic jaundice</strong>: onset &lt;24h, total bilirubin rise &gt;5 mg/dL/day, or persisting &gt;2 wks (term) / 3 wks (preterm)</li>
          <li class="crit"><strong class="hld">Direct (conjugated) bilirubin â‰¥1 mg/dL or &gt;20% of total = ALWAYS pathologic</strong> â†’ evaluate for cholestasis (biliary atresia, neonatal hepatitis, Alagille, TORCH, metabolic)</li>
          <li class="imp">Breastfeeding jaundice (early): inadequate intake â†’ â†‘enterohepatic circulation; encourage breastfeeding; supplement if needed</li>
          <li class="imp">Breast milk jaundice (late): peaks wk 2â€“3; persists up to 3 months; Î²-glucuronidase in breast milk â†’ â†‘enterohepatic circulation; safe, benign; continue breastfeeding</li>
          <li class="crit"><strong class="hld">Kernicterus</strong>: unconjugated bilirubin deposits in basal ganglia, hippocampus, subthalamic nuclei â†’ acute: lethargy, poor feeding, hypotonia â†’ opisthotonos, shrill cry â†’ seizures; chronic: <strong class="hld">choreoathetoid cerebral palsy, sensorineural hearing loss, upward gaze palsy, dental dysplasia</strong></li>
          <li class="imp">Treatment: <strong class="hl">phototherapy</strong> (first-line; isomerizes bilirubin to water-soluble form); <strong class="hld">exchange transfusion</strong> (double-volume; for rapidly rising bili or signs of acute bilirubin encephalopathy)</li>
          <li class="note">Use <strong class="hl">Bhutani/AAP nomogram</strong> to determine phototherapy/exchange transfusion thresholds based on age in hours and risk factors</li>
        </ul>
        <div class="mnemonic">Kernicterus chronic triad: "Choreoid CP + Deaf + Upward gaze palsy" â€” from unconjugated bilirubin toxicity</div>
      </div>
    </div>

    <!-- CH 128 -->
    <div class="chapter-card" data-keywords="hemolytic disease newborn HDN Rh incompatibility ABO Rh sensitization anti-D RhoGAM Coombs test hydrops fetalis erythroblastosis fetalis exchange transfusion intrauterine transfusion">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 128</span>
        <span class="ch-title">Hemolytic Disease of the Newborn (Rh &amp; ABO Incompatibility)</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp"><strong class="hl">Rh incompatibility</strong>: Rh-negative mother, Rh-positive fetus â†’ maternal IgG anti-D crosses placenta â†’ hemolysis; <strong class="hl">first pregnancy spared</strong> (sensitization); subsequent pregnancies at risk</li>
          <li class="imp">Prevention: <strong class="hl">RhoGAM (anti-D immune globulin)</strong> â€” given at 28 wks and within 72h of delivery, miscarriage, trauma; prevents sensitization</li>
          <li class="crit">Severe Rh disease â†’ <strong class="hld">hydrops fetalis</strong>: fetal heart failure + generalized edema + ascites + pleural effusions + polyhydramnios; treat with intrauterine transfusion (IUT)</li>
          <li class="imp"><strong class="hl">ABO incompatibility</strong>: mother O, baby A or B (most common); milder than Rh; <strong class="hl">can occur in first pregnancy</strong> (anti-A/B IgG naturally present); positive DAT (Coombs), spherocytes on smear</li>
          <li class="imp">Both: jaundice within <strong class="hl">first 24 hours</strong> (pathologic!), anemia, hepatosplenomegaly, positive DAT</li>
          <li class="crit">Management: phototherapy; exchange transfusion if bilirubin rising rapidly or dangerously high; IVIG reduces need for exchange</li>
        </ul>
        <div class="mnemonic">Rh vs ABO: "Rh = Requires prior sensitization (1st pregnancy safe); ABO = Anytime (1st pregnancy at risk)"</div>
      </div>
    </div>

  </div>

  <!-- â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• -->
  <!-- SECTION E: NEONATAL INFECTIONS -->
  <!-- â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• -->
  <div class="section-label">Section E â€” Neonatal Infections</div>
  <div class="chapters-grid">

    <!-- CH 129 -->
    <div class="chapter-card" data-keywords="neonatal sepsis early onset late onset GBS E. coli Listeria Staph blood culture CBC CRP lumbar puncture ampicillin gentamicin empiric antibiotics">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 129</span>
        <span class="ch-title">Neonatal Sepsis</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp"><strong class="hl">Early-onset sepsis (EOS)</strong>: â‰¤72h (or â‰¤7 days); acquired vertically; organisms: <strong class="hl">GBS (most common), E. coli, Listeria</strong></li>
          <li class="imp"><strong class="hl">Late-onset sepsis (LOS)</strong>: &gt;72h; nosocomial or community-acquired; organisms: <strong class="hl">CoNS (NICU), Staph aureus, Gram-negatives, Candida</strong></li>
          <li class="crit">Signs: temperature instability, poor feeding, lethargy, apnea, hypoglycemia, jaundice, respiratory distress, bulging fontanelle (meningitis)</li>
          <li class="crit">Empirical antibiotics for EOS: <strong class="hld">ampicillin + gentamicin</strong>; for LOS (NICU): <strong class="hl">vancomycin + gentamicin/cefepime</strong></li>
          <li class="imp">Work-up: CBC + differential, CRP, blood culture (most important), LP (if stable â€” do before antibiotics), urine culture (in LOS)</li>
          <li class="imp">GBS prevention: maternal intrapartum antibiotic prophylaxis (IAP) with <strong class="hl">penicillin G</strong> for GBS-positive mothers, unknown status with risk factors, or prior infant with GBS disease</li>
          <li class="note">Neonatal meningitis: most common organisms = GBS (early), E. coli/Gram-neg (early), GBS/Staph (late); duration of treatment 14â€“21 days; GBS meningitis = 14â€“21 days IV penicillin</li>
        </ul>
        <div class="mnemonic">EOS organisms: "GEL" â†’ GBS, E. coli, Listeria â€” treat with Amp + Gent empirically</div>
      </div>
    </div>

    <!-- CH 130 -->
    <div class="chapter-card" data-keywords="TORCH congenital infections toxoplasma rubella CMV herpes syphilis Zika blueberry muffin hepatosplenomegaly chorioretinitis calcifications hearing loss microcephaly">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 130</span>
        <span class="ch-title">TORCH &amp; Congenital Infections</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">TORCH: <strong class="hl">T</strong>oxoplasma, <strong class="hl">O</strong>ther (syphilis, varicella, Zika, parvovirus), <strong class="hl">R</strong>ubella, <strong class="hl">C</strong>MV, <strong class="hl">H</strong>erpes</li>
          <li class="crit"><strong class="hld">CMV</strong>: most common congenital infection (0.5â€“1% live births); most asymptomatic; symptomatic: <strong class="hl">periventricular calcifications</strong>, microcephaly, chorioretinitis, hepatosplenomegaly, thrombocytopenia, <strong class="hl">"blueberry muffin" rash</strong>, SNHL (most common long-term complication); treat with <strong class="hl">valganciclovir</strong> (symptomatic CNS disease)</li>
          <li class="crit"><strong class="hld">Congenital Toxoplasmosis</strong>: classic triad â€” <strong class="hl">chorioretinitis + hydrocephalus + intracranial calcifications (diffuse)</strong>; cat exposure; treat with pyrimethamine + sulfadiazine + leucovorin Ã— 1 year</li>
          <li class="crit"><strong class="hld">Congenital Rubella</strong>: first trimester most devastating; triad: <strong class="hl">cataracts + sensorineural hearing loss + cardiac defects (PDA, pulmonary artery stenosis)</strong>; blueberry muffin rash; salt-and-pepper retinopathy; no treatment â€” prevention with MMR vaccine</li>
          <li class="crit"><strong class="hld">Congenital Syphilis</strong>: early (&lt;2 yrs): <strong class="hl">rhinitis (snuffles)</strong>, copper-colored maculopapular rash on palms/soles, hepatosplenomegaly, periostitis/osteitis; late: Hutchinson teeth, saber shins, interstitial keratitis, saddle nose; treat with <strong class="hld">penicillin G Ã— 10 days</strong></li>
          <li class="imp"><strong class="hl">Congenital HSV</strong>: peripartum acquisition; skin/eye/mouth (SEM) disease, CNS, or disseminated; treat with IV acyclovir; maternal genital lesions at delivery â†’ C-section</li>
          <li class="note">CMV vs Toxo calcifications: CMV = <strong class="hl">periventricular</strong>; Toxo = <strong class="hl">diffuse/scattered</strong></li>
        </ul>
        <div class="mnemonic">Congenital Rubella: "CAP" â†’ Cataracts, sensorineural deAfness (hearing loss), cardiac (PDA)</div>
      </div>
    </div>

    <!-- CH 131 -->
    <div class="chapter-card" data-keywords="necrotizing enterocolitis NEC preterm bloody stool abdominal distension pneumatosis intestinalis portal venous gas NPO antibiotics surgery Bell staging">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 131</span>
        <span class="ch-title">Necrotizing Enterocolitis (NEC)</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">NEC: ischemic-inflammatory intestinal necrosis; primarily affects premature infants; peak onset 2â€“3 weeks of life; rare in term infants (polycythemia, CHD, asphyxia)</li>
          <li class="imp">Risk factors: prematurity (most important), formula feeding (vs breast milk), rapid feed advancement, hypoxia, polycythemia</li>
          <li class="crit">Clinical: abdominal distension, <strong class="hl">bloody stools</strong>, bilious emesis, temperature instability, apnea, circulatory collapse</li>
          <li class="crit">X-ray: <strong class="hld">pneumatosis intestinalis</strong> (intramural gas â€” pathognomonic), portal venous gas (worse prognosis), pneumoperitoneum (free air = perforation â†’ surgery)</li>
          <li class="imp">Bell staging: I = suspected (mild); II = proven (pneumatosis); III = advanced (perforation, shock)</li>
          <li class="crit">Management: <strong class="hl">NPO, nasogastric decompression, IV fluids, broad-spectrum antibiotics</strong> (ampicillin + gentamicin + metronidazole); <strong class="hld">surgery (peritoneal drain or laparotomy) for perforation or deterioration</strong></li>
          <li class="note">Prevention: <strong class="hl">human breast milk</strong> (â†“NEC 6â€“10Ã—), judicious feed advancement, probiotics (evidence growing)</li>
        </ul>
        <div class="mnemonic">NEC X-ray: "Pneumatosis intestinalis = Pathognomonic for NEC" â€” intramural gas is the key finding</div>
      </div>
    </div>

  </div>

  <!-- â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• -->
  <!-- SECTION F: NEUROLOGICAL & METABOLIC -->
  <!-- â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• -->
  <div class="section-label">Section F â€” Neonatal Neurology &amp; Metabolic Disorders</div>
  <div class="chapters-grid">

    <!-- CH 132 -->
    <div class="chapter-card" data-keywords="HIE hypoxic ischemic encephalopathy birth asphyxia therapeutic hypothermia Sarnat staging seizure EEG MRI outcome cooling blanket">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 132</span>
        <span class="ch-title">Hypoxic-Ischemic Encephalopathy (HIE)</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">HIE: neonatal brain injury from perinatal asphyxia (hypoxia + ischemia); most commonly near-term/term infants; a leading cause of neonatal death and neurodisability</li>
          <li class="imp"><strong class="hl">Sarnat staging</strong>: Mild (I) â€” irritable, hyperalert, â†‘tone, normal EEG; Moderate (II) â€” lethargy, seizures, â†“tone, abnormal EEG; Severe (III) â€” coma, flaccid, burst suppression/flat EEG, multiorgan failure</li>
          <li class="crit"><strong class="hld">Therapeutic hypothermia</strong> (whole body cooling to 33â€“34Â°C Ã— 72h): <strong class="hld">standard of care for moderate-severe HIE in infants â‰¥36 wks</strong>; initiated within 6 hours; â†“death and disability by ~40%</li>
          <li class="imp">Criteria for cooling: â‰¥36 wks GA, evidence of perinatal asphyxia (Apgar â‰¤5 at 10 min, cord pH &lt;7.0, base deficit â‰¥16, or need for resuscitation â‰¥10 min) + moderate-severe encephalopathy</li>
          <li class="imp">Neonatal seizures: subtle (most common â€” lip smacking, eye deviation, cycling), clonic, tonic, myoclonic; treat with phenobarbital (first-line), then levetiracetam, fosphenytoin</li>
          <li class="note">MRI at 5â€“7 days best predicts outcome; watershed injury (moderate HIE) vs deep gray matter injury (severe HIE â€” worse prognosis)</li>
        </ul>
        <div class="mnemonic">Cooling criteria: "â‰¥36 wks + pH&lt;7.0 or BDâ‰¥16 + moderate-severe encephalopathy â†’ Cool within 6 hours"</div>
      </div>
    </div>

    <!-- CH 133 -->
    <div class="chapter-card" data-keywords="neonatal hypoglycemia glucose definition symptomatic asymptomatic IDM SGA preterm treatment dextrose D10W glucagon GIR glucose infusion rate">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 133</span>
        <span class="ch-title">Neonatal Hypoglycemia</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">Neonatal hypoglycemia: blood glucose &lt;47 mg/dL (operational threshold for intervention); symptomatic if: jitteriness, seizures, apnea, poor feeding, hypotonia, lethargy</li>
          <li class="imp">At-risk groups: <strong class="hl">IDM</strong> (hyperinsulinism), <strong class="hl">SGA/IUGR</strong> (â†“glycogen stores), preterm (â†“stores + immature gluconeogenesis), perinatal stress, polycythemia, Beckwith-Wiedemann syndrome</li>
          <li class="crit">Asymptomatic: feed and recheck in 30 min; if persistent â†’ IV glucose; <strong class="hld">symptomatic</strong>: <strong class="hld">IV D10W 2 mL/kg bolus â†’ glucose infusion rate (GIR) 6â€“8 mg/kg/min</strong></li>
          <li class="imp">Persistent hypoglycemia (&gt;GIR 10â€“12): consider <strong class="hl">hyperinsulinism</strong> (congenital â€” KATP channel mutations; Beckwith-Wiedemann); treat with diazoxide (K-ATP channel opener), octreotide, glucagon; pancreatectomy in refractory cases</li>
          <li class="note">Key distinction: IDM has high insulin (â†“ketones); SGA/preterm have low stores but normal insulin (ketones present)</li>
        </ul>
        <div class="mnemonic">Neonatal hypoglycemia Rx: "D-1-0 at 2" â†’ D10W 2 mL/kg IV bolus for symptomatic neonatal hypoglycemia</div>
      </div>
    </div>

    <!-- CH 134 -->
    <div class="chapter-card" data-keywords="neonatal hypocalcemia tetany early late Chvostek Trousseau IDM preterm cow milk phosphate calcium gluconate magnesium hypoparathyroidism DiGeorge">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 134</span>
        <span class="ch-title">Neonatal Hypocalcemia &amp; Other Electrolyte Disorders</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">Neonatal hypocalcemia: iCa &lt;1.1 mmol/L (or total Ca &lt;7.0 mg/dL in term, &lt;6.5 in preterm)</li>
          <li class="imp"><strong class="hl">Early hypocalcemia</strong> (24â€“72h): prematurity, IDM (â†‘calcitonin from maternal hyperglycemia), perinatal asphyxia, hypomagnesemia</li>
          <li class="imp"><strong class="hl">Late hypocalcemia</strong> (after 1 wk): high-phosphate feeds (cow milk), vitamin D deficiency, hypoparathyroidism (DiGeorge 22q11.2 del â€” always check Ca in DiGeorge!)</li>
          <li class="crit">Symptoms: jitteriness, seizures, apnea, Chvostek/Trousseau signs, prolonged QTc on ECG</li>
          <li class="crit">Treatment: <strong class="hl">IV calcium gluconate</strong> (symptomatic/severe) â€” give slowly (risk of bradycardia, tissue necrosis if extravasates); oral Ca supplements for mild/chronic</li>
          <li class="note">Hypomagnesemia (Mg &lt;0.6 mmol/L) can cause refractory hypocalcemia (Mg needed for PTH secretion and action) â€” treat with IV/IM magnesium sulfate</li>
        </ul>
      </div>
    </div>

  </div>

  <!-- â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• -->
  <!-- SECTION G: ORGAN SYSTEM DISORDERS IN NEWBORN -->
  <!-- â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• -->
  <div class="section-label">Section G â€” Organ System Disorders in the Newborn</div>
  <div class="chapters-grid">

    <!-- CH 135 -->
    <div class="chapter-card" data-keywords="neonatal polycythemia hyperviscosity partial exchange transfusion hematocrit venous IDM SGA delayed cord clamping plethora jitteriness hypoglycemia">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 135</span>
        <span class="ch-title">Hematologic Problems of the Newborn</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp"><strong class="hl">Polycythemia</strong>: venous Hct &gt;65%; causes: IDM, SGA, delayed cord clamping, twin-twin transfusion; symptoms: plethora, jitteriness, hypoglycemia, seizures, NEC risk, respiratory distress</li>
          <li class="imp">Treatment: symptomatic polycythemia â†’ <strong class="hl">partial exchange transfusion</strong> (replace blood with NS to dilute); target Hct 50â€“55%</li>
          <li class="imp"><strong class="hl">Hemorrhagic disease of newborn</strong>: Vitamin K deficiency bleeding (VKDB); prevent with IM Vitamin K 1 mg at birth for ALL newborns</li>
          <li class="imp"><strong class="hl">Neonatal thrombocytopenia</strong>: common in NICU; causes: maternal ITP (maternal IgG crosses â†’ â†“fetal platelets), neonatal alloimmune thrombocytopenia (NAIT â€” maternal anti-HPA-1a; platelet transfusion Â± IVIG), sepsis, NEC, asphyxia</li>
          <li class="note">NAIT: most severe; ICH risk; most common cause of fetal/neonatal ICH from thrombocytopenia; treat with IVIG Â± HPA-compatible platelets</li>
          <li class="note">Physiologic anemia of infancy: nadir at 8â€“12 wks (2â€“3 months) in term; earlier and more severe in preterm (anemia of prematurity)</li>
        </ul>
      </div>
    </div>

    <!-- CH 136 -->
    <div class="chapter-card" data-keywords="neonatal cardiac congenital heart disease newborn cyanosis ductal dependent lesion prostaglandin PGE1 hyperoxia test TGA HLHS coarctation critical pulmonary stenosis">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 136</span>
        <span class="ch-title">Cardiac Problems in the Newborn Period</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="crit"><strong class="hld">Ductal-dependent lesions</strong>: depend on PDA for pulmonary or systemic blood flow; close of DA = cardiovascular collapse; treat with <strong class="hld">PGE1 (alprostadil)</strong> to keep DA open</li>
          <li class="imp">Ductal-dependent pulmonary flow: <strong class="hl">critical pulmonary stenosis, pulmonary atresia, tricuspid atresia, Ebstein anomaly</strong> â€” cyanotic, PDA maintains pulmonary flow</li>
          <li class="imp">Ductal-dependent systemic flow: <strong class="hl">HLHS, critical coarctation, critical AS, interrupted aortic arch</strong> â€” shock + absent/weak femoral pulses; PDA maintains systemic flow</li>
          <li class="crit"><strong class="hld">TGA (Transposition of Great Arteries)</strong>: most common <strong class="hld">cyanotic CHD in neonates</strong>; parallel circulations â†’ profound cyanosis; PGE1 + emergency balloon atrial septostomy (Rashkind) â†’ arterial switch operation</li>
          <li class="imp">Hyperoxia test: 100% Oâ‚‚ â†’ PaOâ‚‚ &gt;150 = pulmonary (not cardiac) cause of cyanosis; PaOâ‚‚ &lt;100 = cardiac (fixed Râ†’L shunt)</li>
          <li class="note">PGE1 side effects: apnea (most important â€” may need intubation), fever, hypotension, cutaneous flushing; have intubation ready</li>
        </ul>
        <div class="mnemonic">TGA: "Great vessels are Transposed â†’ parallel circuits â†’ No mixing â†’ Profound cyanosis from birth â†’ PGE1 + BAS â†’ Switch op"</div>
      </div>
    </div>

    <!-- CH 137 -->
    <div class="chapter-card" data-keywords="renal problems newborn acute kidney injury AKI oliguria prerenal renal postrenal posterior urethral valves hydronephrosis urinary tract obstruction Potter sequence electrolytes fluid management">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 137</span>
        <span class="ch-title">Renal &amp; Urologic Problems in the Newborn</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">Neonatal AKI: urine output &lt;0.5 mL/kg/h; most common = <strong class="hl">prerenal</strong> (dehydration, sepsis, perinatal asphyxia)</li>
          <li class="imp"><strong class="hl">Posterior urethral valves (PUV)</strong>: most common cause of severe obstructive uropathy in males; detected on prenatal US (bilateral hydronephrosis + distended bladder); present postnatally as weak urine stream, failure to void, palpable bladder; treat with valve ablation; can cause CKD</li>
          <li class="imp">Normal: void within 24h of birth (if not â†’ rule out obstruction); uric acid crystals in diaper first few days = normal (orange/pink staining â€” "brick dust")</li>
          <li class="note">Potter sequence: bilateral renal agenesis â†’ oligohydramnios â†’ pulmonary hypoplasia + limb deformities + flat facies; incompatible with life</li>
          <li class="note">Hypospadias: urethral meatus on ventral surface of penis; DO NOT circumcise (foreskin used for repair); treat surgically at 6â€“18 months</li>
        </ul>
      </div>
    </div>

    <!-- CH 138 -->
    <div class="chapter-card" data-keywords="neonatal GI esophageal atresia TEF tracheoesophageal fistula duodenal atresia double bubble malrotation volvulus Hirschsprung imperforate anus omphalocele gastroschisis">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 138</span>
        <span class="ch-title">Gastrointestinal Problems in the Newborn</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="crit"><strong class="hld">Esophageal Atresia (EA) + TEF</strong>: most common type C (EA + distal TEF, 85%); coughing/choking with feeds, excessive secretions, unable to pass OG tube; polyhydramnios prenatally; CXR: coiled OG tube in blind pouch; associated VACTERL; surgical repair</li>
          <li class="crit"><strong class="hld">Duodenal Atresia</strong>: "double bubble" on AXR (stomach + proximal duodenum); associated with <strong class="hl">Down syndrome (30%)</strong>; polyhydramnios; bilious emesis; surgical repair (duodenoduodenostomy)</li>
          <li class="crit"><strong class="hld">Malrotation + Midgut Volvulus</strong>: surgical emergency; <strong class="hld">bilious vomiting in neonate = volvulus until proven otherwise</strong>; upper GI contrast study (corkscrew sign); Ladd's procedure</li>
          <li class="imp"><strong class="hl">Hirschsprung Disease</strong>: absence of ganglion cells (aganglionic segment) from rectum proximally; failure to pass meconium in first 48h, abdominal distension, bilious emesis; suction rectal biopsy (gold standard); surgical pull-through</li>
          <li class="imp"><strong class="hl">Omphalocele</strong>: abdominal contents herniate through umbilical ring, covered by peritoneal sac; associated with chromosomal anomalies (Trisomy 18, BWS); <strong class="hl">Gastroschisis</strong>: defect to right of umbilicus, NO sac, NOT associated with chromosomal anomalies, associated with bowel atresia</li>
          <li class="note">First meconium passage: 90% within 24h, 99% within 48h of birth; failure to pass â†’ rule out Hirschsprung, CF, hypothyroidism, imperforate anus</li>
        </ul>
        <div class="mnemonic">Bilious vomiting in neonate: "MALROTATION + VOLVULUS until proven otherwise" â†’ upper GI urgently!</div>
      </div>
    </div>

    <!-- CH 139 -->
    <div class="chapter-card" data-keywords="neonatal skin rash erythema toxicum miliaria pustular melanosis transient neonatal pustular melanosis sebaceous hyperplasia vernix milia mongolian spot hemangioma nevus port wine nevus flammeus">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 139</span>
        <span class="ch-title">Skin Disorders in the Newborn</span>
        <div class="ch-tags"><span class="tag tag-soc">Dermatology</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp"><strong class="hl">Erythema toxicum neonatorum</strong>: benign; yellow-white papules/pustules on erythematous base; eosinophils on smear; appears day 1â€“4; self-resolves; NO treatment</li>
          <li class="imp"><strong class="hl">Transient neonatal pustular melanosis</strong>: more common in dark-skinned infants; pustules at birth â†’ pigmented macules; neutrophils on smear; benign, self-resolves</li>
          <li class="imp"><strong class="hl">Milia</strong>: tiny white epidermal inclusion cysts on nose/cheeks; self-resolve; no treatment</li>
          <li class="imp"><strong class="hl">Mongolian spots</strong>: blue-gray patches, usually over sacrum; Dermal melanocytes; common in Asian/African/Hispanic infants; benign; DOCUMENT to prevent confusion with bruising (child abuse)</li>
          <li class="note"><strong class="hl">Nevus flammeus (port wine stain)</strong>: capillary malformation; persists; if V1 distribution + seizures â†’ Sturge-Weber syndrome (ipsilateral leptomeningeal angioma, glaucoma)</li>
          <li class="note">Salmon patch ("stork bite," "angel kiss"): faded capillary malformation on nape/glabella; common; most fade with time</li>
        </ul>
        <div class="mnemonic">Erythema toxicum vs Pustular melanosis: "Eosinophils = Erythema toxicum; Neutrophils = Pustular melanosis" â€” smear tells them apart</div>
      </div>
    </div>

    <!-- CH 140â€“149: Grouped summary chapters -->
    <!-- CH 140 -->
    <div class="chapter-card" data-keywords="neonatal endocrine congenital hypothyroidism thyroid stimulating hormone TSH newborn screen cretinism levothyroxine congenital adrenal hyperplasia CAH ambiguous genitalia 21-hydroxylase salt wasting virilizing">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 140</span>
        <span class="ch-title">Endocrine Disorders in the Newborn</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="crit"><strong class="hld">Congenital Hypothyroidism</strong>: most common neonatal endocrine disorder; most detected on NBS (â†‘TSH); if untreated â†’ <strong class="hld">cretinism</strong> (intellectual disability, short stature, deafness); treat immediately with <strong class="hl">levothyroxine</strong></li>
          <li class="imp">Congenital hypothyroidism symptoms: prolonged jaundice, hypotonia, constipation, large fontanelle, macroglossia, umbilical hernia, hoarse cry, mottled skin â€” often subtle; NBS is key</li>
          <li class="crit"><strong class="hld">Congenital Adrenal Hyperplasia (CAH)</strong>: 21-hydroxylase deficiency (90%); â†“cortisol + â†“aldosterone + â†‘androgens; AR</li>
          <li class="crit">CAH presentations: <strong class="hl">salt-wasting crisis</strong> (most severe â€” hyponatremia, hyperkalemia, vomiting, shock in first 2â€“3 wks; â†‘17-OHP on NBS); virilizing (â†‘androgens â†’ ambiguous genitalia in females, precocious puberty in males); non-classic (milder)</li>
          <li class="imp">Treatment: hydrocortisone (glucocorticoid replacement) + fludrocortisone (mineralocorticoid) + sodium chloride; stress dosing (3Ã—) during illness</li>
          <li class="note">Ambiguous genitalia workup: karyotype, pelvic US, 17-OHP, electrolytes, testosterone, cortisol â€” multidisciplinary team</li>
        </ul>
        <div class="mnemonic">CAH salt-wasting crisis: "Low Na, High K, Low BP in 2nd week of life â†’ 21-hydroxylase deficiency â†’ check 17-OHP on NBS"</div>
      </div>
    </div>

    <!-- CH 141 -->
    <div class="chapter-card" data-keywords="neonatal seizure subtle tonic clonic myoclonic phenobarbital levetiracetam fosphenytoin EEG amplitude integrated aEEG etiology hypoxia hypoglycemia hypocalcemia infection metabolic pyridoxine">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 141</span>
        <span class="ch-title">Neonatal Seizures</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">Neonatal seizures: different from older children; often <strong class="hl">subtle</strong> (most common) â€” eye deviation/blinking, lip smacking, cycling movements, apnea; tonic/clonic less common</li>
          <li class="imp">Causes: HIE (most common), structural brain malformations, metabolic (hypoglycemia, hypocalcemia, hyponatremia, pyridoxine deficiency), infection (meningitis), stroke, IVH</li>
          <li class="crit">Workup: <strong class="hl">glucose (immediate)</strong>, electrolytes, Ca, Mg, ABG, CBC, culture, LP, EEG (aEEG at bedside), head US/MRI</li>
          <li class="crit">Treatment: <strong class="hl">treat underlying cause first</strong> (glucose, calcium); then <strong class="hl">phenobarbital 20 mg/kg IV</strong> (first-line); then levetiracetam or fosphenytoin; pyridoxine trial if refractory</li>
          <li class="note">EEG essential: many neonatal seizures are electrographic only (no clinical correlate); and clinical movements may not be seizures (jitteriness)</li>
          <li class="note">Jitteriness vs seizures: jitteriness = stimulus-sensitive, suppressible, no eye deviation, no EEG correlation; seizures = not suppressible, often EEG correlation</li>
        </ul>
        <div class="mnemonic">Neonatal seizure Rx: "Glucose â†’ Calcium â†’ Phenobarbital â†’ Levetiracetam â†’ Pyridoxine (if refractory)"</div>
      </div>
    </div>

    <!-- CH 142 -->
    <div class="chapter-card" data-keywords="drug withdrawal neonatal abstinence syndrome NAS neonatal opioid withdrawal NOWS Finnegan score morphine methadone clonidine phenobarbital opioid neonatal treatment NICU">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 142</span>
        <span class="ch-title">Drug Withdrawal (Neonatal Abstinence Syndrome / NOWS)</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-crit">Critical</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">NAS/NOWS: neonatal opioid withdrawal from maternal opioid use (heroin, methadone, buprenorphine, prescription opioids) during pregnancy; opioids most common</li>
          <li class="imp">Onset: heroin (12â€“24h), methadone (36â€“72h), buprenorphine (variable); may be delayed</li>
          <li class="crit">Signs: <strong class="hl">CNS</strong> (irritability, high-pitched cry, jitteriness, seizures), <strong class="hl">GI</strong> (poor feeding, vomiting, diarrhea, weight loss), <strong class="hl">autonomic</strong> (sweating, fever, tachycardia, mottling, yawning, nasal stuffiness)</li>
          <li class="imp">Assessment: <strong class="hl">Finnegan Neonatal Abstinence Scoring System</strong> (FNASS) or NOWS scoring; score â‰¥8 Ã— 3 or â‰¥12 Ã— 2 â†’ pharmacologic treatment</li>
          <li class="imp">Non-pharmacologic: swaddling, low-stimulation environment, rooming-in, breastfeeding (if no contraindications), skin-to-skin â†’ reduces need for medications and length of stay</li>
          <li class="crit">Pharmacologic: <strong class="hl">morphine or methadone</strong> (first-line opioid replacement); clonidine (adjunct); phenobarbital (for non-opioid withdrawal or adjunct)</li>
          <li class="note">Breastfeeding: encouraged if mother on buprenorphine/methadone maintenance and HIV-negative, not using illicit drugs â€” â†“NAS severity</li>
        </ul>
        <div class="mnemonic">NAS signs: "3 Cs" â†’ CNS irritability, GI Cramps/symptoms, autonomic (Cardiovascular/sweating)</div>
      </div>
    </div>

    <!-- CH 143-149 combined -->
    <div class="chapter-card" data-keywords="newborn screening hearing screen ophthalmologic exam discharge follow-up neonatal exam normal newborn well baby care vitamin K erythromycin cord care circumcision SIDS safe sleep">
      <div class="chapter-header" onclick="toggleCard(this)">
        <span class="ch-num">Ch. 143â€“149</span>
        <span class="ch-title">Care of the Normal Newborn, Routine Procedures &amp; SIDS</span>
        <div class="ch-tags"><span class="tag tag-hiy">High Yield</span><span class="tag tag-soc">Preventive</span></div>
        <span class="ch-toggle">âŒ„</span>
      </div>
      <div class="chapter-body">
        <ul class="key-points">
          <li class="imp">Routine newborn care: <strong class="hl">Vitamin K 1 mg IM</strong> (prevents VKDB), <strong class="hl">erythromycin eye ointment</strong> (ophthalmia neonatorum prophylaxis â€” GC &amp; Chlamydia), hepatitis B vaccine (within 12h if mother HBsAg+; otherwise before discharge or within 1 month)</li>
          <li class="imp">Newborn screening (NBS): blood spot at 24â€“48h (earlier can miss some disorders); universal hearing screen before discharge; critical CHD pulse oximetry screening at â‰¥24h</li>
          <li class="imp">Normal newborn physical exam: weight 2.5â€“4 kg; length 48â€“53 cm; OFC 33â€“37 cm; physiologic weight loss up to 10% (regained by 10â€“14 days)</li>
          <li class="imp">Physiologic findings: Epstein pearls, Mongolian spots, acrocyanosis (hands/feet blue â€” normal first 48h), milia, subconjunctival hemorrhage, breast engorgement, vaginal discharge/pseudomenstruation (normal in females), caput succedaneum</li>
          <li class="crit"><strong class="hld">SIDS (Sudden Infant Death Syndrome)</strong>: sudden unexplained death of infant &lt;1 year; peak 2â€“4 months; <strong class="hld">Safe Sleep ABCs: Alone, Back, Crib</strong></li>
          <li class="imp">SIDS risk reduction: <strong class="hl">supine sleep position</strong> (â†“SIDS 50%), firm flat surface, no soft bedding/pillows/bumpers, room-sharing (not bed-sharing), no smoke exposure, breastfeeding, pacifier use; <strong class="hl">no prone sleep until infant can roll independently</strong></li>
          <li class="imp">Circumcision: elective; benefits (â†“UTI, â†“STI, â†“penile cancer) vs risks (bleeding, infection); contraindicated in hypospadias/epispadias, bleeding disorders, micropenis</li>
          <li class="note">Erythema toxicum (benign), physiologic jaundice, and physiologic vaginal discharge are all normal in the first week â€” educate parents</li>
        </ul>
        <div class="mnemonic">Safe Sleep: "ABCs of Safe Sleep" â†’ Alone, Back, Crib â€” the three pillars of SIDS prevention</div>
      </div>
    </div>

  </div>

  <!-- FOOTER -->
  <div class="footer">
    <span>Nelson Textbook of Pediatrics Â· 22nd Ed. Â· 2024</span>
    <span>Part X: Chapters 114â€“149 Â· The Fetus &amp; the Neonatal Infant</span>
  </div>

</div><!-- end page-wrap -->

<script>
  let openedChapters = new Set();
  const TOTAL_CHAPTERS = 36;

  function toggleCard(header) {
    const card = header.parentElement;
    const wasOpen = card.classList.contains('open');
    card.classList.toggle('open');
    const chNum = card.querySelector('.ch-num').textContent;
    if (!wasOpen) openedChapters.add(chNum);
    updateProgress();
  }

  function updateProgress() {
    const opened = openedChapters.size;
    const pct = Math.min((opened / TOTAL_CHAPTERS) * 100, 100);
    document.getElementById('progressFill').style.width = pct + '%';
    document.getElementById('progressText').textContent = `${opened} / ${TOTAL_CHAPTERS} opened`;
  }

  function filterChapters() {
    const q = document.getElementById('searchInput').value.toLowerCase().trim();
    const cards = document.querySelectorAll('.chapter-card');
    let visible = 0;

    cards.forEach(card => {
      const title    = card.querySelector('.ch-title').textContent.toLowerCase();
      const body     = card.querySelector('.chapter-body') ? card.querySelector('.chapter-body').textContent.toLowerCase() : '';
      const keywords = (card.dataset.keywords || '').toLowerCase();

      if (!q || title.includes(q) || body.includes(q) || keywords.includes(q)) {
        card.classList.remove('hidden');
        visible++;
      } else {
        card.classList.add('hidden');
      }
    });

    document.getElementById('chapterCount').textContent = q
      ? `${visible} result${visible !== 1 ? 's' : ''}`
      : `${TOTAL_CHAPTERS} chapters`;
  }

  document.addEventListener('keydown', e => {
    if (e.ctrlKey && e.key === 'e') {
      e.preventDefault();
      document.querySelectorAll('.chapter-card:not(.open)').forEach(c => {
        c.classList.add('open');
        openedChapters.add(c.querySelector('.ch-num').textContent);
      });
      updateProgress();
    }
  });
</script>

</body>
</html>
